Assembly Biosciences ASMB EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Assembly Biosciences’s reported figures.
The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Assembly Biosciences's EBITDA?
- Assembly Biosciences (ASMB) reported EBITDA of -$11.34M in Q1 2026.
- How has Assembly Biosciences's EBITDA changed year-over-year?
- Assembly Biosciences's EBITDA decreased by 14.5% year-over-year, from -$9.91M to -$11.34M.
- What is the long-term trend for Assembly Biosciences's EBITDA?
- Over 3 years (2021 to 2024), Assembly Biosciences's EBITDA has grown at a -30.0% compound annual growth rate (CAGR), from -$132.22M to -$45.29M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.